Hong Kong Baptist University and Cornell University jointly develop a novel nano-carrier that increases the efficacy of Chinese medicine treatment for breast cancer
- Written by Hong Kong Baptist University
HONG KONG SAR - Media OutReach - 11 May 2021 - Researchers from Hong Kong Baptist University (HKBU), in collaboration with Cornell University, have developed a novel targeted therapy for triple-negative breast cancer (TNBC) that uses a specially-designed nano-carrier to deliver the Chinese medicine compound gambogic acid (GA). The invention...